Table 8 LncRNAs and platinum drugs resistance in gastric cancer
From: Noncoding RNAs in gastric cancer: implications for drug resistance
LncRNAs | Expression1 | Genes and Pathways | Drugs | Reference |
|---|---|---|---|---|
PCAT-1 | ↑ | EZH2, PTEN | cisplatin | [161] |
miR-128/ZEB1 | [162] | |||
DANCR | ↑ | MDR1, MRP1 | cisplatin | [163] |
SNHG5 | ↑ | Bax, MDR1, MRP1, Bcl-2 | cisplatin | [164] |
GHET1 | ↑ | Bax, Bcl-2, MDR1, MRP1 | cisplatin | [165] |
AK022798 | ↑ | MRP1, P-gp | cisplatin | [166] |
ANRIL | ↑ | MDR1, MRP1 | cisplatin | [167] |
UCA1 | ↑ | miR-27b | cisplatin | [168] |
HULC | ↑ |  | cisplatin | [169] |
HOTAIR | ↑ | miR-126/PI3K/AKT/MRP1 | cisplatin | [170] |
miR-34a, PI3K/Akt,Wnt/β-catenin | cisplatin | [171] | ||
XLOC_006753 | ↑ | PI3K/AKT/mTOR | cisplatin | [172] |
ZFAS1 | ↑ | Wnt/β-catenin | cisplatin | [173] |
BCAR4 | ↑ | Wnt | cisplatin | [174] |
MALAT1 | ↑ | miR-23b-3p/ATG12 | cisplatin | [175] |
PVT-1 | ↑ | MDR1, MRP, mTOR, HIF-1α | cisplatin | [176] |
BLACAT1 | ↑ | miR-361/ABCB1 | oxaliplatin | [179] |
CASC2 | ↓ | miR-19a | cisplatin | [180] |
CRAL | ↓ | miR-505/CYLD/AKT | cisplatin | [181] |